Targeting inflammation in diabetic nephropathy: a tale of hope (original) (raw)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

Sergio Mezzano

International Journal of Molecular Sciences

View PDFchevron_right

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy

Alberto Martínez-castelao

World journal of diabetes, 2012

View PDFchevron_right

Role of Inflammation in the Pathogenesis of Diabetic Nephropathy

International Journal of Diabetology and Vascular Disease Research (IJDVR)

View PDFchevron_right

Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy

Juan Pablo Manrique Navarro

TheScientificWorldJournal, 2006

View PDFchevron_right

Inflammation in diabetic kidney disease

José Valdivielso

World Journal of Diabetes, 2014

View PDFchevron_right

2 Diabetic nephropathy as an inflammatory disease

Jordi Bover

trnres.com

View PDFchevron_right

Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy

Amit Maiti

International Journal of Molecular Sciences, 2021

View PDFchevron_right

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ

Fátima Cano Cano

International Journal of Molecular Sciences

View PDFchevron_right

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets

Brad Dieter

American Journal of Physiology-Renal Physiology, 2016

View PDFchevron_right

Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy

claudio flores

Journal of The American Society of Nephrology, 2010

View PDFchevron_right

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

gangadhar taduri

Frontiers in Endocrinology, 2013

View PDFchevron_right

Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease

Mark Cooper

Diabetic Nephropathy, 2021

View PDFchevron_right

New Insight into the Molecular Drug Target of Diabetic Nephropathy

Rianto Setiabudy

International Journal of Endocrinology, 2014

View PDFchevron_right

Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways

Jesus Dominguez

Physiological Genomics, 2013

View PDFchevron_right

Overview: Combating Diabetic Nephropathy

Fuad Ziyadeh

Journal of the American Society of Nephrology, 2003

View PDFchevron_right

Novel avenues for treating diabetic nephropathy: new investigational drugs

Domenico Santoro

Expert opinion on investigational drugs, 2017

View PDFchevron_right

New perspectives on markers implicated in signalling pathways that advance diabetic nephropathy and its therapeutic approaches

RAHUL SHARMA

International Journal of Basic & Clinical Pharmacology, 2025

View PDFchevron_right

Molecular Mechanisms of Diabetic Nephropathy , General Preventive Measures and Novel Therapeutic Strategies

Najia Sherzay

2018

View PDFchevron_right

New molecular insights in diabetic nephropathy

Adrian Covic

View PDFchevron_right

Therapeutic Modalities in Diabetic Nephropathy: <i>Future Approaches</i&gt

Emaad Abdel-rahman

Open journal of nephrology, 2012

View PDFchevron_right

Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches

Emaad Abdel-rahman

Journal of General Internal Medicine, 2011

View PDFchevron_right

DIABETIC NEPHROPATHY -GENESIS, PREVENTION AND TREATMENT Review Article

International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)

International journal of Pharmacy and Pharmaceutical Sciences, 2014

View PDFchevron_right

Inflammatory Response to Diabetic Medications in Patients with and Without Diabetic Nephropathy

Najah Hadi

View PDFchevron_right

Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism

Mandeep Arora

Journal of Cardiovascular Pharmacology, 2009

View PDFchevron_right

Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”

Marta Ruiz-ortega

Journal of Clinical Medicine, 2020

View PDFchevron_right

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial

D. Schaumberg

Diabetes Care, 2008

View PDFchevron_right

New molecular insights in diabetic nephropathy · S ¸tefana Bîlha 5,6 · Angelica Gra ˘ma ˘ticu 5,6 · Luminiţa Voroneanu 5,6 · Adrian Covic 5,6

Adrian Covic

View PDFchevron_right

Drug Therapy Targets for Diabetic Nephropathy: An Overview

jasmine jain

International Journal of Pharmaceutical Sciences Review and Research

View PDFchevron_right

The pathogenesis of diabetic nephropathy

George Bakris

Nature Clinical Practice Endocrinology & Metabolism, 2008

View PDFchevron_right

Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression

Dr. Sandra C. Naaman

Diabetes Care

View PDFchevron_right

EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation

Weerapon Sangartit

Endocrinology and Metabolism

View PDFchevron_right

ASK1 inhibitor halts progression of diabetic nephropathy in Nos3 deficient mice

David Nikolic-paterson

Diabetes, 2015

View PDFchevron_right

The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy

Jaw-Wen Chen

International Journal of Molecular Sciences

View PDFchevron_right

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment

Nur Samsu

BioMed Research International, 2021

View PDFchevron_right